Active	Status	Sponsor type	Region	Phase	Filter
32 Active 16 Inactive 48 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DUREZ, Patrick
TIGERS, NCT04261010: TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_() Study	Completed	N/A	36	Europe	Global/single cell gene expression profiles obtained from Synovial biopsies	Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Janssen-Cilag International NV, University Hospital, Ghent	Psoriatic Arthritis	09/23	09/23
Leclercq, Sophie
SELECT MDS-1, NCT04797780 / 2020-004528-40: Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome	Recruiting	3	550	Europe, Canada, US, RoW	Tamibarotene, SY-1425, Placebo, Azacitidine	Syros Pharmaceuticals	Myelodysplastic Syndromes	11/24	02/29
Timary, Philippe de
No trials found
Gallez, Bernard
No trials found
Declerck, Louise
No trials found
Prud'homme, Laura
No trials found
Beuken, Guy
No trials found
Vanacker, Julie
No trials found